Acute Motor and Sensory Axonal Neuropathy (AMSAN) Associated with COVID-19 Infection; A Case Report

Creative Commons License

Sipahioglu H., Elmaagac M., Kantar Y. C., Gunal A. I., Esmaoglu A.

JOURNAL OF EMERGENCY MEDICINE CASE REPORTS, vol.13, no.3, pp.92-94, 2022 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.33706/jemcr.1099690
  • Journal Indexes: Emerging Sources Citation Index (ESCI)
  • Page Numbers: pp.92-94
  • Keywords: AMSAN, COVID-19, Guillain Barre Syndrome, neuropathy
  • Erciyes University Affiliated: Yes


Myalgia and headache are relatively common in COVID-19 disease, but a serious neurological disease is uncommon. In this case, we describe the symptoms and clinic of AMSAN, a rare variant of Guillain Barre syndrome (GBS) due to COVID 19. We presented a case of AMSAN, a rare variant of GBS, in a 46-year-old male patient with poor overall condition that did not recover after COVID-19 disease, loss of strength and decreased sensation in distal limbs. electromyography-nerve conduction study findings were suggestive acute motor and sensory axonal neuropathy. Cerebrospinal fluid analysis was elevated protein with a normal white blood cell count. The clinical diagnosis of AMSAN supported by results of diagnostic testing such as cerebrospinal fluid and electromyography-nerve conduction study.